NASDAQ: ITOS
$10.17
+0.04
(+0.39%)
as on
The stock has been delisted from the stock exchange on 28 Aug 2025
as on August 29, 2025 at 1:29 am IST
Day's Low
0.29%
Downside
52 Week's Low
52 Week's High
52.80%
Downside
73.35%
Upside
Check Iteos Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$-
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Iteos Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $- | NA | NA | 0.00% | |
BUY | $63.2B | 297.83% | -505.15 | -12.96% | |
NA | $39.8B | NA | NA | -3.89% | |
BUY | $101.7B | 55.09% | 28.16 | 31.86% | |
BUY | $59.0B | 1.52% | 14.03 | 31.37% |
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Iteos Therapeutics Inc. Average target price of $10.3
Get share price movements and forecasts by analysts on Iteos Therapeutics Inc.
What analysts predicted
1.26%UPSIDE
Target Price
$10.3
Current Price
$10.17
Analyzed by
11 Analysts
Target
$10.30
Iteos Therapeutics Inc target price $10.3, a slight upside of 1.26% compared to current price of $10.17. According to 11 analysts rating.
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, ITOS stock has moved up by 40.1%
Revenue Rich
Revenue is up for the last 2 quarters, -11.30M → 35.0M (in $), with an average increase of 132.3% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.3% return, outperforming this stock by 171.6%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.5% return, outperforming this stock by 97.2%
Profit Down
Netprofit is down for the last 2 quarters, -34.61M → -78.72M (in $), with an average decrease of 127.5% per quarter
Organisation | Iteos Therapeutics Inc |
E-voting on shares | Click here to vote |
Iteos Therapeutics Inc share price today is $10.17 as on at the close of the market. Iteos Therapeutics Inc share today touched a day high of $10.17 and a low of $10.14.
Iteos Therapeutics Inc share touched a 52 week high of $17.63 on and a 52 week low of $4.8 on . Iteos Therapeutics Inc stock price today i.e. is closed at $10.17,which is 42.31% down from its 52 week high and 111.88% up from its 52 week low.
Indian investors can start investing in Iteos Therapeutics Inc (ITOS) shares with as little as ₹88.098 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.98 in Iteos Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Iteos Therapeutics Inc share’s latest price of $10.17 as on August 29, 2025 at 1:29 am IST, you will get 0.9833 shares of Iteos Therapeutics Inc. Learn more about
fractional shares .